文献速递贫血与红细胞疾病

成人镰状细胞病患者视网膜病变的自然病程与进展速率:一项11年随访研究

Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study.
PubMed 文献 · Blood Adv · 2023-01-01

该回顾性研究分析129例镰状细胞病(SCD)患者,中位随访11年(四分位距8.5-12年),描述镰状细胞视网膜病变(SCR)自然病程并识别进展及增殖性SCR(PSCR)的危险因素。28.7%(37/129)患者出现SCR进展;末次随访时PSCR与年龄较大、HbSC基因型及较低HbF相关,而无SCR与女性、HbSS/HbSβ0/HbSβ+基因型及较高HbF相关。

要点

  • 129例SCD患者中28.7%(37/129)出现SCR进展,中位随访11年。
  • 末次随访时PSCR与年龄较大(aOR 1.073)、HbSC基因型(aOR 25.472)及较低HbF(aOR 0.786)相关。
  • 无SCR与女性(aOR 2.555)、HbSS/HbSβ0/HbSβ+基因型(aOR 3.733)及较高HbF(aOR 1.119)相关。

核心结论

  • SCR在成人SCD患者中可发生进展,年龄较大、HbSC基因型及较低HbF与末次随访时PSCR相关。
  • 女性、HbSS/HbSβ0/HbSβ+基因型及较高HbF与末次随访时无SCR相关。
  • 可考虑对低危或高危患者采取差异化的SCR筛查与随访策略。

研究设计与样本

  • 回顾性分析129例SCD患者的疾病进展,中位随访11年(四分位距8.5-12年)。
  • 患者分为两组:HbSS、HbSβ0-地中海贫血和HbSβ+-地中海贫血组(n=83;64.3%),HbSC组(n=46;35.7%)。

主要发现

  • 28.7%(37/129)患者观察到SCR进展。
  • 末次随访时PSCR与年龄较大相关(aOR 1.073;95%CI 1.024-1.125;P=.003)。
  • 末次随访时PSCR与HbSC基因型相关(aOR 25.472;95%CI 3.788-171.285;P≤0.001)。
  • 末次随访时PSCR与较低HbF相关(aOR 0.786;95%CI 0.623-0.993;P=.043)。
  • 末次随访时无SCR与女性(aOR 2.555;95%CI 1.101-5.931;P=.029)、HbSS/HbSβ0/HbSβ+基因型(aOR 3.733;95%CI 1.131-12.321;P=.031)及较高HbF(aOR 1.119;95%CI 1.007-1.243;P=.037)相关。

临床怎么用

  • 作者认为,可考虑对低危或高危患者采取差异化的SCR筛查与随访策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sickle cell retinopathy (SCR) is a complication of sickle cell disease (SCD). Proliferative SCR (PSCR) can lead to severe visual impairment due to vitreous hemorrhage or retinal detachment. Knowledge of risk factors for progression and complications of SCR is limited. The aim of this study is to describe the natural history of SCR and to identify risk factors for progressive SCR and development of PSCR. We retrospectively analyzed disease progression in 129 patients with SCD with a median follow-up period of 11 years (interquartile range, 8.5-12). Patients were divided in 2 groups. The genotypes hemoglobin SS (HbSS), HbSβ0-thalassemia, and HbSβ+-thalassemia were grouped together (n = 83; 64.3%), whereas patients with HbSC (n = 46; 35.7%) were grouped separately. Progression of SCR was observed in 28.7% (37 of 129) of patients. Older age (adjusted odds ratio [aOR], 1.073; 95% confidence interval [CI], 1.024-1.125; P = .003), HbSC genotype (aOR, 25.472; 95% CI, 3.788-171.285; P ≤ 0.001), and lower HbF (aOR, 0.786; 95% CI, 0.623-0.993; P = .043) were associated with PSCR at end of follow-up. Lack of any SCR at end of follow-up was associated with female sex (aOR, 2.555; 95% CI, 1.101-5.931; P = .029), HbSS/HbSβ0/HbSβ+ genotype (aOR, 3.733; 95% CI, 1.131-12.321; P = .031), and higher HbF levels (aOR, 1.119; 95% CI, 1.007-1.243; P = .037). Differentiated strategies for screening and follow-up of SCR could be considered for patients at low or high risk.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Brandsen RP, Diederen RMH, Bakhlakh S, et al. Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study. Blood Adv. 2023. PMID: 36897257. doi:10.1182/bloodadvances.2022009147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。